Allogene Therapeutics Q2 2025 Earnings Preview

* Allogene Therapeutics (NASDAQ:ALLO [https://seekingalpha.com/symbol/ALLO]) is scheduled to announce Q2 earnings results on Wednesday, August 13th, after market close.
* The consensus EPS Estimate is -$0.27 [https://seekingalpha.com/symbol/ALLO/earnings/estimates] (+22.9% Y/Y)
* Over the last 1 year, ALLO has beaten EPS estimates [https://seekingalpha.com/symbol/ALLO/earnings/eps-surprise-summary] 50% of the time and has beaten revenue estimates 50% of the time.
* Over the last 3 months, EPS estimates have seen 3 upward revisions [https://seekingalpha.com/symbol/ALLO/earnings/revisions] and 1 downward. Revenue estimates have seen 0 upward revisions and 1 downward.

MORE ON ALLOGENE THERAPEUTICS

* Allogene Therapeutics: Buying Around A Potential ASCO Lazarus Moment [https://seekingalpha.com/article/4790995-allogene-therapeutics-buying-around-a-potential-asco-lazarus-moment]
* Allogene Therapeutics: Still Looking Shaky, But Looking To Turn The Corner (Rating Upgrade) [https://seekingalpha.com/article/4790445-allogene-therapeutics-still-looking-shaky-but-looking-to-turn-the-corner]
* SA Asks: Which oncology companies are attractive M&A targets? [https://seekingalpha.com/news/4452742-sa-asks-which-oncology-companies-are-attractive-ma-targets]
* Seeking Alpha’s Quant Rating on Allogene Therapeutics [https://seekingalpha.com/symbol/ALLO/ratings/quant-ratings]
* Historical earnings data for Allogene Therapeutics [https://seekingalpha.com/symbol/ALLO/earnings]